PK

waliving

Time to PK in RuneScape then clean the house then go to a sauna

CryptoApeNL


blalah

Yeah, I don't disagree with you there, using CB or a broker is easier and in some cases far safer than trying to track your own keys. My point was more that crypto is intrinsically different in that there is still a PK, no matter who is holding it, or how many times it's stored or backed up. If that's gone, it's gone. With forming a company and issuing stock it's just a matter of getting the execs and the lawyers in a room for an hour while everyone bangs their dicks on the table and the lawyers leave paid. There's nothing that could make the stock suddenly disappear.

blalah

Would love to see one of these massive ETF holders lose their PK lol

cashflowyield

[https://youtu.be/n\_pRD\_gMy1A?si=PK63pXShXZ7oI0-N&t=5103](https://youtu.be/n_pRD_gMy1A?si=PK63pXShXZ7oI0-N&t=5103)

Many_Easy

I’m long this industry, particularly Tilray Brands. Don’t assume anything. I don’t own any puts or short this industry. As far as soon, he passed that “few weeks” timeline plus he breaks most of his “promises” anyways. POTUS has not made any promises-cannabis promises anyways. PM ≠ PK.

Goopstains6318


reaper527

don't really have one because i'm still in "rebalance my portfolio" mode (and i do that through new purchases, not selling off stuff for the sake of diversifying). UNH and AMZN are my current big "keep buying them" things right now though. (was PK a few months ago until i hit my target for how much of my portfolio i wanted to be real estate)

Electrical-Goal-4163

I found the ticker OVID and the buy rating caught my eye. Asked GTP about any catalysts and this came up. Key Upcoming Catalysts & Their Sources 1. OV329 (GABA-aminotransferase Inhibitor) Phase 1 topline safety, tolerability, and biomarker data expected in Q3 2025 . Phase 2a trial initiation in Q1 2026, with topline results anticipated Q1 2027 . 2. OV350 (First-in-human KCC2 Direct Activator, IV Form) Safety, tolerability, and PK data expected in Q4 2025 . 3. OV4071 (First Oral KCC2 Direct Activator) IND‑enabling studies are underway; first‑in‑human (Phase 1) studies are expected to commence in Q2 2026 . According to the August 2025 corporate presentation, Phase 1 initiation is planned for Q2 2026, with a Phase 1b in patients expected Q3 2026, and topline results by Q1 2027 .

BeneficialSort9477

Interesting one... makes me wonder why they didn't look at plavix too -- this can potentially mitigate the risk of GIB + minimize the first pass effects which is especially important for plavix since hepatic enzyme genotypes significantly impact plavix PK and efficacy?

granddaddychino

Thanks for checking it out. I went ahead and created a brief video. https://youtu.be/Ypfo3eybn6I?si=T-4BuAV7iWMs7PK4

ProfitableFrontier

VT - it's the world Vnqi - land abroad Vnq - land in the US SPSK - Sukkuk as a bond alternative PK - Yolo'ed some money into it a few years ago

snuepe

READ the crash investigation report, no newspapers, no youtube, no netflix. Read the report. And for a short one you can read my comment below. https://www.aaiu.ie/sites/default/files/FRA/2018%20-%20035%20-%20PK-LQP%20Final%20Report.pdf

Dizzy_Maybe8225

| REIT Name | Ticker | Buyback Amount | P/E Ratio | Dividend Yield | Analyst Rating | Market Cap | |-------------------------------|--------|----------------------------|-----------|----------------|----------------|-----------------| | Alexandria Real Estate Equities | ARE | $212.9 million | 23.71 | 7.59% | Hold | $12.04B | | JBG Smith Properties | JBGS | $187.5 million | N/A | 4.06% | Sell | $1.26B | | Host Hotels & Resorts | HST | $100.0 million | 16.08 | 5.16% | Moderate Buy | $10.89B | | Park Hotels & Resorts | PK | $47.3 million | 17.11 | 9.65% | Hold | $2.07B | | Apple Hospitality REIT | APLE | $29.6 million | 14.68 | 8.28% | Moderate Buy | $2.77B | | RLJ Lodging Trust | RLJ | $23.9 million | 28.81 | 8.22% | Hold | $1.10B | | Realty Income Corp. | O | Authorized up to $2.0 billion | 41.70 | 5.69% | Overweight | $51.10B | | Global Net Lease | GNL | Authorized up to $300 million | N/A | 9.79% | Moderate Buy | $1.73B |

Dizzy_Maybe8225

| REIT Name | Ticker | Buyback Amount | P/E Ratio | Dividend Yield | Analyst Rating | Market Cap | |-------------------------------|--------|----------------------------|-----------|----------------|----------------|-----------------| | Alexandria Real Estate Equities | ARE | $212.9 million | 23.71 | 7.59% | Hold | $12.04B | | JBG Smith Properties | JBGS | $187.5 million | N/A | 4.06% | Sell | $1.26B | | Host Hotels & Resorts | HST | $100.0 million | 16.08 | 5.16% | Moderate Buy | $10.89B | | Park Hotels & Resorts | PK | $47.3 million | 17.11 | 9.65% | Hold | $2.07B | | Apple Hospitality REIT | APLE | $29.6 million | 14.68 | 8.28% | Moderate Buy | $2.77B | | RLJ Lodging Trust | RLJ | $23.9 million | 28.81 | 8.22% | Hold | $1.10B | | Realty Income Corp. | O | Authorized up to $2.0 billion | 41.70 | 5.69% | Overweight | $51.10B | | Global Net Lease | GNL | Authorized up to $300 million | N/A | 9.79% | Moderate Buy | $1.73B |

WenMunSun

My god bro wtf are you talking about... i'm an American and i used to own BYD in 2009. It's called the OTC market, ticker [BYYDF.PK](http://BYYDF.PK) Americans CAN own BYD and have always been allowed to own BYD. Back to for you

AppleTree98

The FED straight up created magical funds to make the who SIVB and SBNY members whole. Go ahead and look it up. Ok i'll grab a quick search. * [**Guaranteed Deposits**](https://www.google.com/search?cs=1&sca_esv=f24ca8b027933cc4&sxsrf=AHTn8zrqGwhiqd7gG1WlC-eHPMRu9HtZKg%3A1747882205154&q=Guaranteed+Deposits&sa=X&ved=2ahUKEwj3mo3PiLaNAxW2DEQIHb9zCAwQxccNegQIEBAB&mstk=AUtExfBy5ZqJQT9PQgVHePRpqUqU10kmIftdTxVZWqpni1UwpcRgzUNpWhy0kuoDBp8ndsf4hbNJtG6ewYg4qN0bHvdzBImZwPVx9skqotLuA4rktLckT_GYZoOujmIhcRTUuG5PK6lfva7SNfIoSeFm-NSkd05S8hyifN2A-GMRKxFomeQ&csui=3)**:**.Opens in new tabThe FDIC, along with the Federal Reserve and Treasury, guaranteed all deposits at SIVB and SBNY, including those exceeding the standard $250,000 FDIC insurance limit. This meant depositors, regardless of their deposit amount, would receive their full funds.  * [**Liquidity Support**](https://www.google.com/search?cs=1&sca_esv=f24ca8b027933cc4&sxsrf=AHTn8zrqGwhiqd7gG1WlC-eHPMRu9HtZKg%3A1747882205154&q=Liquidity+Support&sa=X&ved=2ahUKEwj3mo3PiLaNAxW2DEQIHb9zCAwQxccNegQIExAB&mstk=AUtExfBy5ZqJQT9PQgVHePRpqUqU10kmIftdTxVZWqpni1UwpcRgzUNpWhy0kuoDBp8ndsf4hbNJtG6ewYg4qN0bHvdzBImZwPVx9skqotLuA4rktLckT_GYZoOujmIhcRTUuG5PK6lfva7SNfIoSeFm-NSkd05S8hyifN2A-GMRKxFomeQ&csui=3)**:**.Opens in new tabThe Fed created a new [Bank Term Funding Program (BTFP)](https://www.google.com/search?cs=1&sca_esv=f24ca8b027933cc4&sxsrf=AHTn8zrqGwhiqd7gG1WlC-eHPMRu9HtZKg%3A1747882205154&q=Bank+Term+Funding+Program+%28BTFP%29&sa=X&ved=2ahUKEwj3mo3PiLaNAxW2DEQIHb9zCAwQxccNegQIJBAB&mstk=AUtExfBy5ZqJQT9PQgVHePRpqUqU10kmIftdTxVZWqpni1UwpcRgzUNpWhy0kuoDBp8ndsf4hbNJtG6ewYg4qN0bHvdzBImZwPVx9skqotLuA4rktLckT_GYZoOujmIhcRTUuG5PK6lfva7SNfIoSeFm-NSkd05S8hyifN2A-GMRKxFomeQ&csui=3) to provide liquidity to other banks, helping them meet depositors' needs and prevent further bank runs. This program offered loans backed by collateral to eligible depository institutions.  * [**No Taxpayer Funding:**.Opens in new tab](https://www.google.com/search?cs=1&sca_esv=f24ca8b027933cc4&sxsrf=AHTn8zrqGwhiqd7gG1WlC-eHPMRu9HtZKg%3A1747882205154&q=No+Taxpayer+Funding&sa=X&ved=2ahUKEwj3mo3PiLaNAxW2DEQIHb9zCAwQxccNegQIJhAD&mstk=AUtExfBy5ZqJQT9PQgVHePRpqUqU10kmIftdTxVZWqpni1UwpcRgzUNpWhy0kuoDBp8ndsf4hbNJtG6ewYg4qN0bHvdzBImZwPVx9skqotLuA4rktLckT_GYZoOujmIhcRTUuG5PK6lfva7SNfIoSeFm-NSkd05S8hyifN2A-GMRKxFomeQ&csui=3)The FDIC emphasized that no taxpayer money would be used to cover the losses associated with SIVB and SBNY. The FDIC's [Deposit Insurance Fund](https://www.google.com/search?cs=1&sca_esv=f24ca8b027933cc4&sxsrf=AHTn8zrqGwhiqd7gG1WlC-eHPMRu9HtZKg%3A1747882205154&q=Deposit+Insurance+Fund&sa=X&ved=2ahUKEwj3mo3PiLaNAxW2DEQIHb9zCAwQxccNegQIIBAB&mstk=AUtExfBy5ZqJQT9PQgVHePRpqUqU10kmIftdTxVZWqpni1UwpcRgzUNpWhy0kuoDBp8ndsf4hbNJtG6ewYg4qN0bHvdzBImZwPVx9skqotLuA4rktLckT_GYZoOujmIhcRTUuG5PK6lfva7SNfIoSeFm-NSkd05S8hyifN2A-GMRKxFomeQ&csui=3) (DIF), which is funded by assessments on banks, would be used to cover any losses. 

reaper527

still love the companies i picked up when first entering the market in 2020 (PEP, MO, IRM, XOM, IBM, T), the last few weeks have been picking up PK (a REIT)

reaper527

> anyone buying this week? * bought some PK (real estate was under-represented in my portfolio and i'm in the process of rebalancing as i make new purchases) * closed my january 2026 csp on intc $20 (10 contracts, net profit ~50%) * opened a csp on UNH at $310 for 7/18 (1 contract) view UNH as a risky play, but with an almost $22/share premium i'm reasonably confident that position closes out in the green in a few months

Yorokobi_to_itami

[oh yeah they have great fundamentals ](https://youtube.com/shorts/h05XLFbHl3o?si=a1yAEy5vP8VS4QS9) [I couldn't think](https://youtu.be/IQJL3htsDyQ?si=6k5vGwyLgtLkE9TK) [of a single](https://youtu.be/46bOzXx2iZI?si=-E0jZ5qvWZ6yDdwz) [thing that would](https://youtu.be/PK_EJ3DyiiA?si=Yt9d5nwCo4xO_2yJ) [Make people](https://youtube.com/shorts/uVSZ7KMJKWg?si=V71X3j_yK0tkMHtk) [people think that](https://youtu.be/Z-qWmlYm_bE?si=QgHcfFIw4_toDD0J) [think Tesla ](https://youtube.com/shorts/6AudXd_1YaI?si=MFDsDLlM1zrqh9JQ) [or any of elons](https://youtu.be/-KneSpxzvFg?si=ZbBfEyu1D_7gXtzC) [products are faulty](https://youtu.be/gai1buBArmM?si=D0t7fe3RWw9TFZzo) [I mean seriously it's not like all his products are shit](https://youtu.be/K5vDWhMHTwE?si=1D5ZkYotR6UYqohL)

sleepyspar

PK?  0002? Is at least one of those real?

aeternus_hypertrophy

Oh boy wsb is gonna be spicy while this kicks off. Half this post's comments are like 3 users who frequent either IN/PK related subs

Josepth_Blowsepth

$1 says China is behind the Pakistan escalation of India threatening nukes. China will step in and get both countries to settle down. Look good in the process and diminish the US role and make themselves look level headed and not a chaos monkey. They need PK to stay intact for CPEC and do not need to deal with the fallout of a war. Will get a bit more heated and Xi will step in. Markets will run faster then a loose pig in a Hong Kong alleyway.

chiisushedjiddb

I’m Bon at 0.14. Made some good money playing the PK spikes!

TingGreaterThanOC

Yes  https://m.youtube.com/watch?v=PK_EJ3DyiiA?t=18m30s

MorrisseysRubiksCube

PK Ripper

Infinite_Prize287

Bought more PK today for the first time since 2020, then noticed that PFE has the same dividend, so I bought some more shares and $30c for June 

Forward_Ant_9074

Thanks for your insight! I’m no longer planning to buy more; comments around here changed my mind quite a bit w.r.t hotel REITs in general I’ll just be keeping my current PK stash until the difference between stock valuation and their hotels’ replacement value decreases to <1.5x or so. Right now it’s like 2x, so it’ll likely require buybacks as discussed in their recent call

Forward_Ant_9074

Thanks, agree, I’ll not be increasing my position. Will decrease it to 25% or so when PK is at my breakeven (+5% from current price). Appreciate your comment

dvdmovie1

"Currently my 40% portfolio is $PK" I would never put 40% of my portfolio in anything, but particularly a hotel REIT which get absolutely obliterated any time there's the slightest slowdown. I mean, look at BHR, APLE, DRH, AHT, SOHO, PK, PEB and others - all hotel REITs, all still below or well below where they were in 2019 and eventually we're going to have a recession again. This subsector of REITs really does have kind of a terrible track record and you'd be better off just investing in MAR/HLT. Is PK cheap? Sure. It's definitely cheap but we've had this period where travel has been back and it just keeps eroding. Where's it going to be when things do actually start to turn South in the economy? I mean, PK has been a public company now for close to a decade and the share price track record is -55%. Good luck to you and hope you do well but I can understand 2-3% to this as a value play but definitely not 40% or anything remotely close to that. You have a sector of REITs that hasn't really done all that great when times are good and then gets obliterated the moment things turn South.

OpportunityDue90

No not even close. Generics are almost identical to brand products and must be on a population level. [It’s true that the PK values are required to fall between 80% and 125% of the reference value in these randomized, crossover trials. More importantly, however, the entire 90% confidence interval (CI) of the observed PK value must also fall between 80% and 125%. As a general reminder, CIs are ranges of values we can be confident the true result falls, which in this case is 90% of the time.](https://www.pharmacytimes.com/view/debunking-a-common-pharmacy-myth-the-80-125-bioequivalence-rule) The same is true for AUC which is exposure to the drug.

slowlearner890

If PK was a great buy then, it is a screaming buy now.

BULLSONYA

RXRX to report: Phase I monotherapy safety and pharmacokinetic and pharmacodynamic (PK/PD) data for REC-617 on Dec. 9 during the American Association for Cancer Research special conference in Toronto - RXRX has a 20 billion pipeline guarantee. Leader in AI drug development, and just bought their competitor.

BULLSONYA

RXRX to report: Phase I monotherapy safety and pharmacokinetic and pharmacodynamic (PK/PD) data for REC-617 on Dec. 9 during the American Association for Cancer Research special conference in Toronto - RXRX has a 20 billion pipeline guarantee. Leader in AI drug development, and just bought their competitor.

BULLSONYA

RXRX to report: Phase I monotherapy safety and pharmacokinetic and pharmacodynamic (PK/PD) data for REC-617 on Dec. 9 during the American Association for Cancer Research special conference in Toronto - RXRX has a 20 billion pipeline guarantee. Leader in AI drug development, and just bought their competitor.

thirtydelta

Phase I monotherapy safety and pharmacokinetic and pharmacodynamic (PK/PD) data for REC-617 on Dec. 9 during the American Association for Cancer Research special conference in Toronto

Maximum_Wash_8047

The company is expected to report preliminary data from another Phase 1 trial of PYX-106, including PK/pharmacodynamic results, by the end of 2024. Beyond that my main point is that this market reaction doesn't make sense. RBC Capital even increased their price target from $7 to $10. Most of the coverage on this news has been positive (check any article about it beyond the one you mentioned). I believe this is simply an overreaction that will correct soon. Then, of course by mid-2025, there will be new major catalysts, but there simply was no rationale for this huge collapse, especially considering the financial position which looks quite solid as of now considering it's a biotech.

RyannayR11

Their PK study shows that results are with 95% confidence. This leaves a margin of error that is larger than urine or blood tests. Could this limit its applications and demand? I mean, who wants to buy a drug test device with a 5% error rate?

Ashamed-Subject-8573

2: no. Stop listening to hype from techbros trying to sell their products. https://youtu.be/wZRV2H4PK0Q?si=uFF_vZYO1gYQvJou

Piorz

I wanted to look more into it and stand corrected. Here is what I found: If you own put options on stocks of a company that has just declared or filed for bankruptcy, you are in for a huge reward. The delivery and settlement of every stock option is guaranteed by the OCC, Options Clearing Corporation, in the US Market. Whoever sold you that right to sell shares of that company at that higher price is obliged to fulfill that obligation, so your profit is guaranteed. The only question is, what happens when that company files for bankruptcy and trading in its stocks and options are suspended? When that happens, trading of that company’s stocks and options moves to the Over The Counter (OTC) market or what is known as “Pink Sheet” market where you are able to either sell those put options for a profit or exercise the options and sell the stocks for the same profit. Since it is the company that is going illquid and insolvent and not the person or institution who sold you those put options, you are guaranteed your profit and delivery. The most recent example of this are put options on the collasped Lehman Brothers (ex-Ticker : LEH) which filed for bankruptcy on 14 Sep 2008. After filing for bankruptcy, Lehman Brothers’ shares moved from the exchange to the OTC market (Ticker Symbol LEHMQ or LEHMQ.PK) where it traded at $0.05 per share on 18 Sep 2008. That is when put option holders can choose to exercise the put options by buying the shares at $0.05 and selling it at the strike price for a big profit.

shadi150

Ima PK you on OSRS if you don't calm down

Daddy_Dudley10101

Positions or PK 

Enough_Aerie1283

What will outperform S&P index funds like VOO is growth and simple moderate leverage index funds. Individual stock picking runs risks. Simple leverage on indexes gains benefits like self rebalancing and avoidance of tax events while still targeting higher than market growth. A simple growth buy and hold portfolio: Russel 1000 growth ETF ( $VONG) + 2X S&P500 ($SSO) + 2X Nasdaq-100 ($QLD) Following is the 15yr backtest for this portfolio vs. indexes for the cash flow scenario you presented. Drawdown risk can be further mitigated by respecting the S&P 200MA rule for your leveraged ETF positions. https://testfol.io/?d=eJytkEFrhDAQhf%2FKMoeeIkRb2eJtQdpLKYqwUMoiU41u2pjYmCpF%2FO8dkbXbHkoPG3II82be9yYj1Mq8oErQYtNBNELn0Lq8RCcggoDzrcd9usBA6PK7Htx4%2FNbzt1RfJnpUEF1zOgywfM2lrhQ6aTREFapOMCiwO1bKDGvbqZBXVryT65NAqz7J0RqlpK7zQepy7veDiUFrrKuMkoZiPo%2BgsZmTZFfJJuSchqTuRedi2cuSklKTsx9EtYLWQ12Iu18QJ4s3YRez5U3q3hiSWmELoR2BOZ8ODEqLNUR8Yiv2cZfFu9TzL0dO0%2FRf5Ew2rRKbe2sGd9wkp0%2B5WIyH%2BDxGEM7oVc0684e6N7o%2Bl8MfKxymL4KXyvA%3D

kronco

Gray Line bus tour in Honolulu. As we passed the Hilton the guide told everyone to buy PK (a hotel REIT), cause he was "all in" (except, as he lamented, he could not invest in it in his 401K). (I was impressed a tour bus line had a 401K for the employees.) Morninbgstar rates it four stars with a fair market value of $25 (currently at about $15). Several people pulled out their phone when he mentioned it; seems everyone loves a random stock tip :)

Key-Tie2542

I don't think that's true. I think the highly leveraged leisure have dropped due to interest rates. Things like PK (hotel REIT) have dropped, but things like HLT are at ATHs; and PK is rising strong today. Discretionary like BOOT, ANF, TJX, and so forth are way up. I think what we've seen is the interest rate scare, and what we haven't seen is the recession scare.

Emergency-Eye-2165

PK?

Dbow2thedome

PK me in the wildy N00B

Unitedtendies

England literally begging for PK 😂🤡

Quickoneonit

Bro I got strike on my account for saying I’d PK u in osrs lmao

Key_Security_1569

Ya ALTards are crazy man.. VKTX > ALT VKTX catalysts in the next 8 months. 1. Type C meet with FDA 2. Ph2 Venture PK data 3. July earnings poss FDA update 4. VK2809 Nash biopsy data 5. VK2735 oral extra cohorts results 6. Obesity week presentations 7. Vk2735 oral Ph2 starts 8. VK2735 SubQ Ph3 or Ph2b Buyout at 15-20B

IJesusChrist

Dude phase 1 is not exclusively for safety. You collect biomarkers and you can look at pharmacodynamics and titer responses. When a company's trial goes bad in phase 1 they will tell you the primary goal is to establish safety and PK. If it goes good they will tell you they saw exactly what they wanted to see: in this case, seropositivity or seronegative rates, viral titers, etc. Please god.

Bsquared-order66

Obviously I can’t speak as an insider pro and all regions might have different profit times of the year. But since it’s a stock that’s tied to the total company and company’s profit and not that a regions profit, a look at the bigger picture is a must. While Phoenix area could be killing it, the rest of the flagship locations might be dwindling pulling down the entire company / stock price. That’s also assuming stock value was fundamental based and not decided on what someone tweeted about. So all this crap could be just that, crap and PK stock goes boom Tuesday and I look like an dbag. My hope is that your call makes you $ honestly.

Bsquared-order66

https://preview.redd.it/209phy6tqe2d1.jpeg?width=960&format=pjpg&auto=webp&s=2c66ae63667284d6280aece96eb9152540c09b90 I pulled this seasonality chart of PK for you. Although there tends to be a spike at beginning of June it’s a heavy drop off couple weeks later that tends to last till end of August. Not trying to hate or give advice either way. Honestly Just trying to help. Everything I see is pointed against a long play here at this time. Maybe a short spike with a quick few bucks. But with the 4 EMA going under the 8 EMA, I’m staying away unless it’s a put or short.

callmemaverik_

I disagree with the conventions and transient part. Transients absolutely spend more and book higher rates than group rates. Of course, it comes down to the type of hotel and its location. Near a convention center? Absolutely. Location location location. However, I'd feel more comfortable investing in Hilton or Marriott than I would PK. They already have the branding and people already losing trust in AirBNB.

Bsquared-order66

In all sincerity, with an ex wife in the hotel business, the summers aren’t always their busy months. Most hotels rely on convention business and not Transient business (aka families on vacay). Families consist far less revenue both on room rates and practically zero on food and beverage. I’d look toward the stocks chart and watch the 4 and 8 EMA averages on the daily graph and weekly charts. Once that 4 overtakes that 8 it’s gonna go down and vice versa. That’s what appears to be happening with PK on both charts now. So you would be betting against the going current. I try to remind myself not to swim against the current of the market and go with the flow. Wait till the daily chart 8 ema over takes the 4 ema and then for security, if you want more, wait on the weekly chart 8 to overtake the 4 and a modest move should open before tides turn again. But that’s just something I’ve learned. This is not advice of what you should do with your business and $. But I confident hotels make the most income off of conventions staying at their hotel while eating and drinking their food.

lancevancelives

PK = 🚀 That's really all we need. Basically an analyst rating without the confusing numbers. 

Disastrous_Dot_6941

Anyone jump on the PK dd ? Lol

Hightargets

PK follow Up - from DD from last post The post: Pk stock hit its ATH of 24 dollars in 2020 because travel trends in 2020-21 brought 86 billion to the us economy. Pk price is at 17 right now, near its regardly considerable high 18 price zone (it’s 52 week high). Get this, For 2024, statista analyst project a whopping 110 billion dollars year in revenue streams for the American travel industry. In a nut shell PK = Wendy’s combo meal

Unfair-Log2016

Held PK for a long time and it did nothing and went nowhere. Couldn’t break 18 dollars

Quickoneonit

Bro I got a 1st account warning for violence against another user… because I said I’d PK that one mod in the wilderness  wtf is going on here

Quickoneonit

This mod better not post about how we cant talk ab meme stocks tomorrow or else ima PK him while he's in the wilderness

veryworst

D2 and PK vibes need to come back NOW

HardwoodGuy87

I bought 15k bitcoin in 2010, and my dad threw out my laptop with my PK on it.

Mean-Wait6990

Lol, the guy decided to go against the Argentine mentality in PK.

ninkorn

did he miss his PK?

unitegondwanaland

Same. They are on my watch list now. They also just got a $100M injection on top of the good news announced. > SAN DIEGO, March 12, 2024 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced positive topline results from the second cohort of patients in its Phase 1b MAD study of RGLS8429 for the treatment of ADPKD. >The Phase 1b MAD study is a double-blind, placebo-controlled trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics (PK/PD) of RGLS8429 in adult patients with ADPKD. The study is evaluating RGLS8429 treatment across three different weight-based dose levels, including measuring changes in urinary polycystins 1 and 2 (PC1 and PC2), height-adjusted total kidney volume (htTKV), cyst architecture, and overall kidney function. PC1 and PC2 are the protein products of the PKD1 and PKD2 genes and have been shown to inversely correlate with disease severity. The third cohort is being dosed at 3mg/kg of RGLS8429 or placebo every other week for three months. The Company recently added a fourth cohort for an open label fixed dose of 300mg of RGLS8429 dosed every other week for three months. Based on the results from this second cohort, the Company plans to amend the protocol to increase the sample size to up to 30 patients. In addition to PC1 and PC2 and safety, imaging biomarkers will also be evaluated. >SAN DIEGO, March 12, 2024 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that it has entered into a definitive securities purchase agreement in connection with a private placement to certain institutional investors and other accredited investors. The oversubscribed financing includes participation from new and existing institutional investors, including Adage Capital Partners L.P., Deep Track Capital, the Federated Hermes Kaufmann Funds, New Enterprise Associates (NEA), Octagon Capital, RA Capital Management, and Vivo Capital. Upon the closing of the financing, which is anticipated to occur on or about March 14, 2024, the Company expects to receive gross proceeds of approximately $100 million. The closing of the financing is subject to customary closing conditions.

kronco

\>> a stock that I follow For individual stocks, I find it best to read the full analysis for anything I'm investing in and draw conclusions for that. For example, the morningstar analysis of PK is 2200 words, and covers Business Strategy and Outlook, Financial Strength, Economic Moat, Fair Value and Profit Drivers, Risk and Uncertainty and Capital Allocation. You digest that and make a decision. But the simple charts with thumbs up/down (but/sell/hold), not so much.

kronco

I think it's important to also now what the stars mean. It is different for stocks vs. funds. [https://www.morningstar.com/views/research/ratings](https://www.morningstar.com/views/research/ratings) Funds: *Introduced in 1985, the Morningstar Rating TM for funds, often called the star rating, compares funds against their peers to inform investment decision-making. It's an at-a-glance look at a fund's risk-adjusted performance over the past three years.* Stocks: *The stock star rating is calculated by comparing a stock's current market price with Morningstar's estimate of the stock's fair value. The further the market price is below the fair value, the higher the star rating. A 5-star rating means the stock is trading meaningfully below fair value.* They also list the price range where a stock drops to one star. An example is PK selling at $15.90 with a Fair Value estimate around $26. They give it 5 stars at the current price. If the price was $26 it would be one star. If it hits aprox $21, three stars.

kronco

PK. Park Hotels & Resorts Inc. Bus driver on the #2 pink line in Honolulu recommended it as we drove past the Waikiki Hilton at the end of the tour. That was October when it was at $12. Closed today at $14.89 (up 23%). Pays a 9% dividend. Morningstar \*\*\*\*\* with a Fair Market value estimate of $26 (uncertainty: High). Remember: The best tips come from tour bus drivers and Reddit.

OlliBoi2

 Integrated Cannabis Solutions Inc (IGPK)  Post#  of 46536 GoNext 10   Reply/Post    More  Prev Next  TooFrank  Re: sicofbs post# 41475 Tuesday, 01/16/2024 9:10:08 AM OTC/SEC Disclosure is a legal document unlike a PR or Tweet. Quarterly Report For the period ending September 30, 2023 (the “Reporting Period”) https://www.otcmarkets.com/otcapi/company/financial-report/389366/content The Company has rescinded its agreements with Consolidated, Global, and Tahoe, and dissolved Houdini Group. Management has resigned, and new management has taken over. The new entity is JFH Digital ECommerce Corp. They will be making updates on OTC and the State of NV over the coming weeks. The September 30, 2023 financials reflect the Company prior to JFH merging in. Closing, and the shares of Series A were issued to the incoming company along with shares of common stock.All officers and directors resigned, and below is a list of the new incoming management team: officers and directors resigned, and below is a list of the new incoming management team: 1. CEO: Wang Dejun - Room #1801, Building #5, Vanke Jinyu International Garden, No.144, Houjie Section, Guantai Road, Houjie Town, Dongguan City, Guangdong Province, China 2. CFO: Xie Weiji - No. 3, Changgang Village, Hedong Village Committee, Longjing Town, Qingxin County, Guangdong Province, China 3. Yang Lanfang - Chishuiwan International Hotel, No. 1 General Road, Shexian County, Handan City, Hebei Province, China 4. Zhu Henian - Room #302, Unit one, Building #2, International Industry Center, Zhanggong District, Ganzhou City, Jiangxi Province, China 5. Wang Wei - Building #16, Sunshine Garden, Chengdong Street, Qianjiang District, Chongqing City, China When it comes to the OTC and money, a tick can swallow a cow. 👍️ 1   Share  Replies (3)  Reply/Post    More  Prev Next IGPK Intergrated Cannabis Solutions Inc (PK) 0.01085  -0.00205 (-15.89%) Volume:96,184,373Day Range:0.0093 - 0.0133Bid:0.0107Ask:0.011Last Trade Time:4:00:14 PM ESTTotal Trades:1,667 1D 1M 3M 6M 1Y 5Y  IGPK Detailed Quote   InvestorsHub NewsWire FEATURED Goldshore Announces an Indicated Mineral Resource Estimate of 1,535Koz Contained Gold at 1.23 g/t Au and an Inferred Mineral Resource Estimate of 5,198Koz Contained Gold at 1.11 g/t Au at the Moss Gold Project • Feb 6, 2024 10:22 AM FEATURED Music Licensing, Inc. (OTC: SONG) to Provide Shareholder Update and Financial Statements for Year-End 2023 • Feb 6, 2024 9:45 AM FEATURED Golden Heaven Group Holdings Ltd. Releases 2024 Chairman's Letter to Shareholders • Feb 6, 2024 9:09 AM Toggle3D.ai Announces its Breakthrough AI Increases 3D Model Production For Ecommerce Productivity by 100% • TGGL • Feb 6, 2024 10:00 AM ARway.ai The Spatial Computing Company Launches Apple Vision Pro Compatibility and Early Access for ARwayKit SDK For Augmented Reality Navigation • ARWYF • Feb 6, 2024 10:00 AM Swifty Global Announces Outstanding Performance in 2023 Shareholder Report • DRCR • Feb 6, 2024 9:30 AM Start posting your company's news Only $200 per official company press release!  © Copyright 2024    About Us Terms of Service Privacy Policy Advertise With Us Data Accreditations Disclaimer FAQ Handbook Q&A Forum Contact Us Corporate Solutions Educational Channel Stock Market 101 Investor Help Forum iHub NewsWire    

NOT_MartinShkreli

Thanks man. I appreciate it. I do believe in the company but the key to a bubble is most others don’t notice it and u think this is one I bought in when they started working with pharmacy PK data to dose busulfan and a handful of other drugs. However I’ve seen not much advancement in that space other than a couple new drugs (gotta feed it the patient data + years to validate the model as a clinical trial basically) I LOVE NVDA but I’m smart enough to know that when WSB is pumping it and the mentions are going crazy …. The top is in. It happened with gamestop. It happened with TSLA. It happened with most EV companies. It happened with SNAP, I could go on I will buy the dip … in this case I’m selling a top

Trzebs

Here's your source:  https://youtu.be/r7l0Rq9E8MY?si=NKZi9Qzf6tVVu6PK

DuplicateDestroyer

**Your submission has been removed because it has been posted on the subreddit recently.** **OP:** WilliamBlack97AI **Date:** 2024-01-26 17:01:55 **Dimensions:** 140x78 **Duplicates:** N | User | Date | Posted... | Image Similarity | Text Similarity | Dimensions | Title :-:|:-:|:-:|:-:|:-:|:-:|:-:|:-: 1 | [/u/WilliamBlack97AI](https://www.reddit.com/user/WilliamBlack97AI) | 2024-01-26 17:01:55 | at the same time | [100%](https://a.thumbs.redditmedia.com/QFYjjqc5getvTUgo6lkSif5fBnXkMVY__1x8PK9kMc8.jpg) | N/A | 140x78 | [High Tide Founder and CEO Raj Grover and Finn Hänsel, CEO of Sanity Group, joined Benzinga's Cannabis podcast to talk about their plans for Germany and beyond in 2024](https://redd.it/1abn5x3) I am a bot. If you believe this was sent in error, [please message the subreddit moderators here](https://www.reddit.com/message/compose?to=%2Fr%2Fweedstocks&subject=My+post+has+been+wrongfully+removed&message=My%20post%20has%20been%20wrongfully%20removed%20by%20your%20repost%20bot,%20/u/DuplicateDestroyer. Here%20is%20a%20link%20to%20my%20post : https://redd.it/1abn5x3). **Do not delete your post or moderators won't be able to review it.**

sigmatrophic

not all mutations are virulent or viable of a virus... retro's are the same. Cancer is similar in that respect but traditional chemo relies both on a sledge hammer approach and tissue / delivery PK issues.

TTTTsixandtwo

Thanks, but this looks slightly better than my full realized P/L. If you look at the other "updates" for this play, I've been after it for a while. If I were to close my $PK positions right now, I've have an all time P/L of about $20k gain. But I'm holding these shares through Q4 exdiv and then re-evaluate since things are changing so quickly.

GME_retard-rocket

[https://www.youtube.com/watch?v=PK-J5yDGGoQ](https://www.youtube.com/watch?v=PK-J5yDGGoQ)

Ill_One_OTC

$BLEG &#x200B; **Branded Legacy, Inc. (BLEG) Expands Portfolio with Comprehensive Acquisition of MariJ Pharmaceuticals Inc, Including Licenses, Organic Certifications, and Substantial AssetsPress Release | 12/05/2023** MELBOURNE, Fla., Dec. 05, 2023 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC.PK: BLEG), a key player in the biotech industry, is excited to announce its largest acquisition to date, MariJ Pharmaceuticals, Inc. The deal significantly expands Branded Legacy's asset base and intellectual property portfolio with a landmark acquisition. The deal brings an impressive suite of physical and IP assets including a compounding pharmacy license, a cutting-edge supercritical CO2 extraction unit, inventory of certified organic refined CBD, a fleet of licensed and permitted vehicles – ingeniously modified to house a complete extraction facility, a state-of-the-art refinement lab, and food-safe production area. The acquisition further includes an array of vital operational tools, such as advanced chillers, refrigerators, precision scales, an industrial biomass grinder, and a diverse selection of terpenes, flavorings, and essential lab supplies as well as a patent. Branded Legacy, Inc. has taken a significant leap in its expansion strategy by acquiring MariJ Pharmaceuticals, a company celebrated for its award-winning organic products and expertise in the CBD and wellness industry. This acquisition represents the integration of MariJ's entire operational framework, including its multiple formulations and products with proven track records of profitability, into Branded Legacy, Inc. The deal encompasses two separate companies under the MariJ umbrella, each contributing unique strengths and licensing support for market presence to Branded Legacy's growing portfolio. The acquisition of MariJ by Branded Legacy, Inc. notably includes two specialized trucks (an International and a Freightliner), engineered to enhance operational flexibility and reach. One truck is a fully-equipped mobile extraction facility, designed for on-site processing of raw materials into high-quality extracts. The second truck serves as a dual-purpose food-safe space and refinement lab, adhering to strict health and safety standards. Additionally, a mobile repair service truck (an F250), with all necessary tools and equipment, ensures the maintenance and efficiency of these unique assets. These trucks, permitted in multiple states including Colorado and Tennessee, embody a significant leap in Branded Legacy's capabilities, particularly with the inclusion of a compounding pharmaceutical license. This strategic acquisition not only expands the company's physical assets but also its geographical footprint and service offerings. Moreover, the acquisition extends to MariJ's digital and intellectual property, customer and operational databases, formulations, CRM, as well as multiple domains and websites. The deal also includes permits, a patent for extraction and processing, trademarks, and organic certifications, further solidifying Branded Legacy, Inc.'s asset profile. "The complete acquisition of MariJ is a strategic move that aligns perfectly with our vision for growth and market leadership," stated Dave Oswald, CEO of Branded Legacy, Inc. "This acquisition not only enhances our product range and production capabilities but also brings in a wealth of intellectual property, history, data, and operational assets that will be instrumental in our future endeavors." The acquisition is a combination of preferred series stock and cash. The shares issued will have a buyback option as well as a lockout/leak agreement, reflecting Branded Legacy, Inc.'s commitment to sustainable growth and shareholder value. The closing of the acquisition was consummated on December 4, 2023, marking a significant milestone in the company's journey. Rick Pertile, CEO of MariJ Pharmaceuticals conveys trust and confidence in the deal, he adds "I am thrilled to witness the immense potential of Branded Legacy. My decision to accept stock with such stringent restrictions is a testament to my confidence in the company's future growth. I foresee a significant increase in value, making this agreement a no-brainer for me. I am excited to be part of this journey and look forward to the remarkable advancements we can achieve together." As Branded Legacy, Inc. integrates MariJ's assets and capabilities, the company is poised to deliver enhanced products and services to its customers, reinforcing its commitment to excellence in the health and wellness industry. About MariJ Pharmaceuticals, Inc.: MariJ Pharmaceuticals, Inc., based in Clearwater, Florida, specializes in the certified organic mobile extraction and production of CBD from industrial hemp. They offer a range of cannabinoid products and services tailored for the pharmaceutical and bio-product industries, ensuring compliance with legal THC limits. Their expertise extends to mobile CO2 certified organic, patented extraction services and the legal distribution of both wholesale and retail products in all U.S. markets. MariJ is also known for its commitment to HIPAA compliance and good corporate governance. More information can be found at the MariJ Website About Branded Legacy, Inc.: Branded Legacy, Inc. (OTC: BLEG) is a diversified holdings company focused on the biotech sector. With a commitment to excellence and innovation, Branded Legacy specializes in the development and marketing of cutting-edge products and services. The company's diverse portfolio includes ventures in biotechnology, digital solutions, and wellness products, all aimed at enhancing the quality of life for its customers. Branded Legacy's strategic approach to growth involves identifying and integrating promising businesses and technologies that align with its mission to deliver sustainable, high-quality products and services. Original Copy of this Press Release: [https://brandedlegacy.com/branded-legacy-inc-bleg-expands-portfolio-with-comprehensive-acquisition-of-marij-pharmaceuticals-inc-including-licenses-organic-certifications-and-substantial-assets/](https://brandedlegacy.com/branded-legacy-inc-bleg-expands-portfolio-with-comprehensive-acquisition-of-marij-pharmaceuticals-inc-including-licenses-organic-certifications-and-substantial-assets/) [https://www.otcmarkets.com/stock/BLEG/news/Branded-Legacy-Inc-BLEG-Expands-Portfolio-with-Comprehensive-Acquisition-of-MariJ-Pharmaceuticals-Inc-Including-Licenses?id=423645](https://www.otcmarkets.com/stock/BLEG/news/Branded-Legacy-Inc-BLEG-Expands-Portfolio-with-Comprehensive-Acquisition-of-MariJ-Pharmaceuticals-Inc-Including-Licenses?id=423645)

Technical-Scale-2587

The goat is bringing GME to the stars with him apparently DAMN !! Check the link to find out what is happening. https://youtu.be/w02wAeggh14?si=PK1s_t8ZgYuPR9WH

AltruisticDetail6266

how you put that in the basket? print PK ?

Crustysockshow

12PK Eggs: $2.99 Multipack round steak: $5.99 3 potato’s: $1.99 Or Oatmeal: $1.50 Rotisserie chicken: $4.99 2lb Rice: $1.99 Tortillas: $1.99 Hot sauce: 99¢ or free if you grab some packets Or 12PK Eggs: $2.99 Bread: $1.99 Cheese: $2.99 Lunch meat: $3.50 I could literally go on and on and on. All options give you a breakfest, lunch/dinner option and have multiple servings. If you can’t figure out a way to eat for $12, you either can’t cook or not creative enough. Nowadays with TikTok and YouTube, there’s no excuse for not knowing how to cook for cheap

Potrzebie3

"What Happens To Put Options During Bankruptcy? If you own put options on stocks of a company that has just declared or filed for bankruptcy, you are in for a huge reward. The delivery and settlement of every stock option is guaranteed by the OCC, Options Clearing Corporation, in the US Market. Whoever sold you that right to sell shares of that company at that higher price is obliged to fulfill that obligation, so your profit is guaranteed. The only question is, what happens when that company files for bankruptcy and trading in its stocks and options are suspended? When that happens, trading of that company's stocks and options moves to the Over The Counter (OTC) market or what is known as "Pink Sheet" market where you are able to either sell those put options for a profit or exercise the options and sell the stocks for the same profit. Since it is the company that is going illquid and insolvent and not the person or institution who sold you those put options, you are guaranteed your profit and delivery. "The most recent example of this are put options on the collasped Lehman Brothers (ex-Ticker : LEH) which filed for bankruptcy on 14 Sep 2008. After filing for bankruptcy, Lehman Brothers' shares moved from the exchange to the OTC market (Ticker Symbol LEHMQ or LEHMQ.PK) where it traded at $0.05 per share on 18 Sep 2008. That is when put option holders can choose to exercise the put options by buying the shares at $0.05 and selling it at the strike price for a big profit." [https://web.archive.org/web/20100725103850/https://www.optiontradingpedia.com/what\_happens\_to\_options\_during\_bankruptcy.htm](https://web.archive.org/web/20100725103850/https://www.optiontradingpedia.com/what_happens_to_options_during_bankruptcy.htm) NOTE: When I worked in an OTC firm on Wall Street in the 1960s(!) when a firm ceased to trade the trading brokers who had listed it in the Pink Sheets would continue to buy the shares for pennies, indefinitely, so that stockholders and option traders could close out their positions (or exercise their (put) options).

Enron__Musk

Ummm...no. GLP-1 stands for glucagon like peptide. > GLP-1 is an incretin glucoregulatory hormone released from the gut in response to food ingestion, which stimulates insulin release and decreases glucagon secretion when plasma glucose levels are elevated.8, 24 GLP-1 RAs are synthetic analogues or mimetics of the native human GLP-1 with improved PK properties and more stable PD profiles, thereby providing pharmacological effects greater than endogenous GLP-1 (Table 2).13 GLP-1 RAs bind to GLP-1 receptors that are widely expressed in a number of tissues throughout the body, for example in pancreatic islet cells, as well as cells in the kidney, lung, heart, brain and gastrointestinal tract.25, 26 GLP-1 RAs are included in various clinical practice guidelines for T2D4, 6, 7; however, they differ substantially in their duration of action, molecular size and structure, homology to endogenous GLP-1, chemical and physiological properties and affinity for the GLP-1 receptor (Table 2). > The core effect of GLP-1 RAs in T2D is good glycaemic control, which is achieved through effects on GLP-1 receptors in the pancreas, essentially stimulating insulin release from pancreatic islet β-cells in a glucose-dependent manner and suppressing glucagon secretion from pancreatic islet alpha (α)-cells, which contributes to the reduction in blood glucose levels in people with hyperglycaemia. https://onlinelibrary.wiley.com/doi/full/10.1111/jcpt.13230#:~:text=GLP%2D1%20is%20an%20incretin,plasma%20glucose%20levels%20are%20elevated. Leptin is a completely different pathway.

kronco

I own O, SPG, and a little PK with REIT limited to 5% of portfolio.

glensdale

Hey all, I bought about 5k worth of stocks during COVID lows on the recommendation of a friend who is way more into this stuff than I am (i.e. I had no strategy going in, which I'm aware was dumb). At one point the portfolio was up to 12 or 13k total value, now it's back down to 7.5k. Since I don't put the proper time into this, I want to sell and be done with it but this seems like a bad time judging by all the recent drops. I don't know anyone now that can give me any advice and the research I've done myself hasn't been very helpful. For an inexperienced person like me, is it better to keep waiting? Major positions: VTI SAVE PK PLAY Particularly concerned about SAVE as I've heard about the airline's struggles and the potential merger. Currently it's still above my $11.56 average share cost, but barely.

WeeklyHeretic

What PK is saying here is, "JP Bro. You are killing my bag, man. You smoked it my dude. Take a chill."

GoneFishin56

PK is fraudster. Graph with data was modified to manipulate public opinion in favor of his idol.

GivemTheDDD

"What do you mean? Graph high on the left, graph low on the right. No more thinking required. Just look at the graph and do no additional research... please" - PK probably

Nightblood83

So, prices races up and they've stopped racing up quite as much. Acting like last year is the baseline is scummy as fuck. PK is scummy as fuck. Keynes was an asshole. Google it.

Affectionate_Cup9112

From a newsletter he sent out today: At this point, however, I’m pretty sure that most working economists consider a year to be too long a lag. The inflation situation is changing rapidly, probably because we are finally working out the supply kinks caused by the pandemic. If we look at core inflation, which excludes volatile food and energy prices, the one-year inflation rate is still unacceptably high, but over the past three months inflation has run at only 2.4 percent, and even this number partly reflects delayed effects of a shelter-price surge that ended many months ago: (3/6/12 mo core cpi- most of the increase was toward 12 months ago) It might be a few months before we’re willing to declare victory in the war on inflation, but we won’t need a run of improving data — if the next few months look like the past few, we’ll basically be there. https://messaging-custom-newsletters.nytimes.com/template/oakv2?campaign_id=116&emc=edit_pk_20230915&instance_id=102868&nl=paul-krugman&productCode=PK&regi_id=58010194&segment_id=144869&te=1&uri=nyt%3A%2F%2Fnewsletter%2F7e034197-3348-5736-814f-863dee7b72f2&user_id=c2c07f4ba230cdfbbe246a798f1dcfbc

SPAC_Time

[SAGALIAM ACQUISITION CORP. ANNOUNCES EXECUTION OF DEFINITIVE BUSINESS COMBINATION AGREEMENT AND RECEIPT OF NASDAQ LISTING DELINQUENCY LETTER](https://www.globenewswire.com/news-release/2023/09/15/2744256/0/en/SAGALIAM-ACQUISITION-CORP-ANNOUNCES-EXECUTION-OF-DEFINITIVE-BUSINESS-COMBINATION-AGREEMENT-AND-RECEIPT-OF-NASDAQ-LISTING-DELINQUENCY-LETTER.html) \- SAGA SAGAR Not your typical definitive agreement headline. "The Company has executed a binding business combination agreement for the purchase of Biogenysis, Inc. ("BGEN") and Virogentics Inc. ("VIRO"), operating subsidiaries of Enzolytics Inc. (OTC PK: ENZC). The combined company is expected to trade on NASDAQ." Enzxolytics [announced the non-binding LOI](https://www.accesswire.com/749459/Enzolytics-Inc-Announces-Execution-of-Non-Binding-Term-Sheet-with-the-Special-Purpose-Acquisition-Company-Sagaliam-Acquisition-Corp-and-Updates-the-Progress-on-the-African-Project) for this deal in April.

Technical_Pressure40

Last message didn't send for some reason, so I will try so write a similar one, yuppers333. I am an investor in multiple P2P loans and other crowdfunding platforms for years. I mainly focus on investment platforms that multiple institutions regulate, just to be safe. All of these investment platforms are one of the safest in Europe (especially PK, which I will mention below with additional information). I don’t want to sound like a jerk by only showcasing these sites, so I will also provide reviews made by other sites and other statistics. At the end of the day, these are alternative investments, and you should diversify as much as possible in various places. Note: I invest in all of these platforms, so I’ll leave more information below. 1.P2P - [paskoluklubas.lt](https://www.paskoluklubas.lt/en/registration/investor?ref=ARM845) This is a P2P platform (from 2014, so it’s well-tested) to invest in people’s loans. Loans usually range between 100 to dozens of thousands of euros. By law, the maximum amount you can invest in each loan is 500 EUR (you can invest in the same consumer after 12 months if that 500 limit is reached); however, I would not advise going all-in at once – start slowly with as little as 20 EUR (minimum amount per loan) and diversify your portfolio to lower the risk. It’s not necessary to invest in every single loan – learn to analyze loans and information about the borrower. This platform has a buyback guarantee (A+ loans, 50 EUR minimum) if they default. Other loan levels are A, B, C, and C-; the risky the loan is, the higher the interest rate is. At the moment, loans range between 8%-25% yearly interest rate. Loans time range between a few months to 120 months (loans with 1-3 months have a tendency to have a 30-40% yearly interest rate). I recommend starting with lower interest rates first, and then once you learn to operate and invest, you can increase your risk tolerance accordingly. I personally usually invest in 18%-24% interest rates, and I think these are pretty good returns because you can’t expect such high returns in the US. The main reason why I highly recommend this P2P platform over others is because this platform is among the largest with the highest regulations, which makes it the safest platform in Europe, with new loans added every single day. The platform has a secondary market to sell/buy loans, the ability to automatically invest with wanted filters and other settings, and even VIP bonuses (depending on how large the portfolio is). Funding or withdrawing cash takes a minute (I mean if it’s a wire transfer, it could take a day or so, but it really depends on where you live. For me, it takes less than a minute to receive cash into my bank account). And if you have at least 5k in euros, you won’t have to pay 1 EUR per month for the operational costs – it’s part of the VIP system in the [paskoluklubas.lt](https://www.paskoluklubas.lt/en/registration/investor?ref=ARM845) If you are interested in PK’s reviews or statistical data, feel free to check the following sites: * https://crowdsearch.eu/platforms/paskolu-klubas/ (can be a little bit outdated because interest rates are generally larger nowadays, but the structure is pretty much the same); * https://www.paskoluklubas.lt/en/statistics for official statistics (institutions regulate these, so these are 100% genuine). Before registering, you can also use the “**ARM845**” promo code, which will give back 1% of your invested amount for 3 months straight (I believe it takes up to 30 days for these rewards to be funded into your account). It’s totally up to you if you want to use this promo or register organically. I’m happy to help, either way. 2.Semi-P2P (a combination with the crowdfunding platform) – [https://www.finbee.lt/en/invest/](https://www.finbee.lt/en/invest/) – it works very similarly like [paskoluklubas.lt](https://www.paskoluklubas.lt/en/registration/investor?ref=ARM845) does. They have a different loan tier system (up to a D rating). The interest rate is a bit smaller, but still pretty competitive. It also has a secondary market like PK does, but the downside is that you will need to always pay that 1 EUR per month no matter how large your portfolio is. The minimum investment is 5 EUR. I don’t have a promo code for this platform, unfortunately, so I will leave reviews and statistical data below: * https://crowdsearch.eu/platforms/finbee/ * https://www.finbee.lt/en/reports/ * https://p2pmarketdata.com/platforms/finbee/ 3.P2P [gosavy.com](https://mano.gosavy.com/en/account/ref/237897/) – also works similarly to [paskoluklubas.lt](https://www.paskoluklubas.lt/en/registration/investor?ref=ARM845) and finbee.com. I don’t invest here as much due to more risky loans, so I still prefer [paskoluklubas.lt](https://www.paskoluklubas.lt/en/registration/investor?ref=ARM845). There’s a buyback guarantee program, a secondary market, auto-investments, and of course, regulated by the bank. The minimum investment is 10 EUR per loan. You can use the “237897” code when signing up to receive 20 EUR for your first investment, but it’s not required. These are reviews and other statistical data: * https://crowdsearch.eu/platforms/savy/ * [https://gosavy.com/statistika](https://gosavy-com.translate.goog/statistika/?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=lt&_x_tr_pto=wapp) (for some reason it kept redirecting to Lithuanian site, but I have used Google to translate this page to make it easier for you. 4.Crowdfunding [profitus.com](https://ss.profitus.lt/register?ref=utnpqxcafn) active from 2018 – This platform finances large projects rather than personal loans, so if you are into that, you might be interested in this platform, too. [profitus.com](https://ss.profitus.lt/register?ref=utnpqxcafn) crowdfunding platform requires a minimum of 100 EUR investment on any project, but you can use the “utnpqxcafn” code to receive a 25 EUR bonus for your first investment. As previously mentioned, it’s up to you whether you want to register with a code or without. In my opinion, that’s a pretty good deal to start with a first investment, but it’s up to you. New projects appear daily, but it may take a week or two to finance these large projects (in rare cases, large projects can be financed within the same day). While P2P has a 500 EUR limit per loan, crowdfunding (business) projects do not have a limit - you can invest as much as you want, but I’d suggest diversifying your portfolio before taking on large projects. Inserting review and statistics below: * https://crowdsearch.eu/platforms/profitus/ * https://p2pmarketdata.com/platforms/profitus/analysis/ * https://www.profitus.com/statistics 5.Crowdfunding [nordstreet.com](https://nordstreet.com/register?referral=NS616845) \- similar to [profitus.com](https://ss.profitus.lt/register?ref=utnpqxcafn), NordStreet has been known to fund projects over the whole Europe. It offers 3 different investment categories: 1) Business loans secured by RE pledge; 2) Business loans; and 3) Investing in buy-to-let mortgage (real estate rental), as well as the company’s private stocks. My favorite is business loans secured by property pledges because I can earn the most with the most guarantees. The minimum investment is 100 EUR. However, I made a huge mistake when investing in Spanish projects when they defaulted, and due to Spanish laws, there are complications and a long process to recover money back, but I will eventually get all the investments + interest + late interest + processing fees, so I will double the money by the time I recover it. I personally invest in Lithuanian, Latvian, and Estonian projects the most; in my opinion, they are the safest option. Here are some additional resources with statistics down below: * https://p2pmarketdata.com/platforms/nordstreet/ * https://nordstreet.com/statistics **TL;DR - summarized sites for P2P and crowdfunding platforms to earn interest rates as a passive income:** **1. P2P** [paskoluklubas.lt](https://www.paskoluklubas.lt/en/registration/investor?ref=ARM845) **2. P2P** [https://www.finbee.lt/en/invest/](https://www.finbee.lt/en/invest/) **3. P2P** [gosavy.com](https://mano.gosavy.com/en/account/ref/237897/) **4. Crowdfunding** [profitus.com](https://ss.profitus.lt/register?ref=utnpqxcafn) **5. Crowdfunding** [nordstreet.com](https://nordstreet.com/register?referral=NS616845) Of course, this is not financial advice, but if there is anything I could do to prove these platforms are safe, just hit me up, and I will provide resources with my experiences. If you are interested in alternative investments, this could be a great way to have passive income.

NOT_MartinShkreli

This is a TERRIBLE play honestly. I actually did research on ADHD meds, extended release formulations, PK-PD, etc. This is NOT NOT a good med formulation. This is iso-pure adderall basically. These amphetamines have a much longer 1/2 life than methylphenidate. As a result, these elevated blood levels deep into the afternoon will keep people up awake all night. There is zero reason to take this. That extended time means 4-6 hours of ACTION still occurring. Only thing this drug formulation will be good for is insomnia.

Serious-Contract-915

PK Cohort data results for Z-Endoxifen to evaluate breast density in patients, as well as Q2 earnings. No one releases bad news on a Monday before the bell

Inevitable-Tank137

https://youtu.be/PK2SMIOHYig

lipmanz

PK with the nice reversal

EPLFantasyGuru

PK chu?

Turtlesaur

Anyone still bullish on PK?

groommer

Great DD, I just loaded up on PK shares so I'm sure it will go bankrupt. But I appreciate the DD. It can't be worse than my BLNK postal contract play. Or selling ZIM before the special dividend, or anything else I've ever traded.

issaanonymousguy

Ok I'm convinced, in on PK and INN

mars987

Bro is comping PK to HT and BHR 😂😂?? HT and BHR are probably the worst comps in hotel land… BHR is an externally managed REIT and HT is so teeny tiny that its not even close to comparable. If you truly wanna make a lodging reit play I would go into HST, it has the lowest leverage vs peers and the highest quality portfolio. PK is ok but it has a worse portfolio and worse leverage. Other (more comparable) lodging reits include SHO, XHR, DRH, PEB and maybe a few others arguably. This autist is conflating office with lodging which I do not think is the case, but lodging overall may not be the worst play. If you’re playing earning PK isn’t bad since they report first, but that’s about it.